Please take our brief survey by clicking on the right hand side. (Videos from our Jan. and Mar. Scotiabank Awareness Nights are still being edited and will be available soon.)

Advanced Prostate Cancer

Increased Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer.

March 6, 2015

Androgen deprivation therapy (ADT) may increase diabetes risk. As benefits of primary ADT (PADT) for localized PCa are controversial, and most PCa survivors are of advanced age with comorbidities, it is important to determine if PADT increases diabetes risk and what are the susceptibility factors. Read the article.  (Free UroToday login required.)

Read the article or watch the video →

UroToday Introduces Advanced Prostate Cancer Treatment Video Channel

January 16, 2015

UroToday has expanded its video-on-demand content in the UrologyTUBE™ with a new video channel featuring multi-media lectures focusing on treatment of men with advanced prostate cancer. The new channel specifically focuses on androgen deprivation treatment (hormone treatment) as the backbone of advanced prostate cancer treatment. View the channel.  (Free UroToday login required.)  

Read the article or watch the video →

Bipolar Androgen Therapy

January 9, 2015

Research hope for prostate cancer Pouring petrol on the fire can potentially reverse resistance to hormone treatments for prostate cancer, new research suggests. The counter-intuitive strategy called bipolar androgen therapy (BAT) involves boosting levels of the male hormone testosterone, which normally stimulates prostate cancer growth. In a small pilot study, scientists found that alternating high […]

Read the article or watch the video →

Advances in Prostate Cancer: 2014

December 13, 2014

The year 2014 has again provided important developments in the area of prostate cancer. New data and new treatments span the spectrum of prostate cancer management, from prevention and screening to optimal strategies for localized, locally advanced, and metastatic disease. Read the article.  (Free Medscape account required.)

Read the article or watch the video →

Managing bone health in patients with prostate cancer

October 29, 2014

Department of Surgery, University of Toronto, Humber River Hospital, Toronto, Ontario, Canada BARKIN J. How I Do It: Managing bone health in patients with prostate cancer. Can J Urol 2014;21(4): 7399-7403. Urologists have two scenarios where they have to address bone loss or increased risk of fractures in men with prostate cancer. In the first […]

Read the article or watch the video →

Chemo-ADT Combo Ups Survival in Patients with Metastatic PCa

July 15, 2014

Starting chemotherapy along with androgen deprivation therapy (ADT) in patients newly diagnosed with metastatic prostate cancer (mPCa) improved median overall survival by more than 13 months, according to a study presented at the American Society of Clinical Oncology annual meeting in Chicago. Read the article.

Read the article or watch the video →

Treatment Sequencing in Metastatic Castrate Resistant Prostate Cancer

July 1, 2014

Six different treatments have demonstrated improved survival in phase III trials targeted to patients with metastatic castration-resistant prostate cancer (mCRPC). Front-line therapeutic options for mCRPC include docetaxel, sipuleucel-T, abiraterone and radium-223. Post-docetaxel options include cabazitaxel, abiraterone, enzalutamide and radium-223. Despite much progress in recent years, much is yet unknown and debates occur over optimal treatment […]

Read the article or watch the video →

Videos: Early Detection of Metastatic Prostate Cancer

April 29, 2014

This site has a number of videos on early detection of metastatic prostate cancer. View them here.

Read the article or watch the video →

Videos on Advance Prostate Cancer

March 8, 2014

Click here to access a number of videos on advanced prostate cancer.

Read the article or watch the video →

Supervised Exercise Helps ADT Patients

February 25, 2014

Commencing a supervised exercise program involving aerobic and resistance exercise when initiating ADT significantly reduced treatment toxicity while improving social functioning and mental health. Concurrent prescription of supervised exercise when initiating ADT is therefore advised to minimise morbidity associated with severe hypogonadism. Read the article.  (This article is in UroToday; a free login may be […]

Read the article or watch the video →